Hilton San Francisco Financial District, San Francisco, US
Innovation, collaboration and best practice for pharma, biotech and partners
Conference day three: Thursday 2nd February
Please enable javascript to see more information on speakers
The Future Therapeutic Business Model | |||
| 8am | Registration and coffee | ||
| 8.50am |
Chairman’s opening remarks
| ||
Disruptive thinking: evaluating the status quo | |||
| 9am |
Invigorating innovation for biotechnological research
| ||
| 9.25am |
Moving from bankrupt blockbusters to breakthroughs
| ||
| 9.50am |
Recalculating the changing parameters of venture capital investments
| ||
| 10.15am |
Building a bridge between the valley of death
| ||
| 10.40am |
Panel: bringing new motion to global inertial forces Mr Bernard MunosBernard Munos is the founder of the InnoThink Center for Research in Biomedical Innovation, which was created to translate innovation research into better evidence-based business models for the pharmaceutical industry and its stakeholders. Before... more.. Dr. Corey GoodmanDr. Corey Goodman is a Founding Partner of venBio – a new life sciences strategic capital company working with Amgen, Baxter, and PPD. With a B.S. from Stanford University and Ph.D. from U.C. Berkeley, he spent 25 years as a biology professor at... more.. Dr. Barbara HandelinDr. Handelin is a veteran entrepreneur and molecular medical geneticist who has pioneered the responsible application of genetics to clinical medicine over a 25 year career. In 1987 Dr. Handelin established one of the first commercial DNA testing... more..
| ||
| 11.20am | Morning coffee break | ||
Changing cost-effectiveness into cost-value | |||
| 11.50am |
Blockbuster economics: measuring risk for uncertain investments
| ||
| 12.20pm |
Compromising innovation in the race to ROI
| ||
| 12.50pm |
Panel session: moving beyond the cost-effectiveness band-aid Dr. Arthur DeVanyAuthor of The New Evolution Diet and Hollywood Economics, the most acclaimed book on the movie business One of the most original thinkers in health who recast diet and fitness in terms of evolution and complexity, Dr. De Vany is called the... more..Dr. Barbara HandelinDr. Handelin is a veteran entrepreneur and molecular medical geneticist who has pioneered the responsible application of genetics to clinical medicine over a 25 year career. In 1987 Dr. Handelin established one of the first commercial DNA testing... more.. Dr. Joseph MiletichJoseph P. Miletich, M.D, Ph.D. is Senior Vice President, Research and Development at Amgen, Inc. where he created and leads the company’s innovative Translational Sciences organization. This critical part of Amgen’s R&D effort unlocks the promise of ... more..
| ||
| 1.20pm | Networking lunch | ||
Creating new business models | |||
| 2.20pm |
Pin-pointing pharmaceutical strengths to maximize prospective business growth
| ||
| 2.55pm |
Building visionary ideas into best practices
| ||
| 3.20pm |
Building innovation from a micro-pharmaceutical approach
| ||
| 3.45pm | Afternoon coffee break | ||
| 4.15pm |
Driving innovation in the early stage ecosystem through venture capital
| ||
| 4.40pm |
Panel session: what should the new business model include? Ms. Lesa MitchellLesa Mitchell is a vice president with the Kauffman Foundation. She has been responsible for the Foundation’s frontier work in understanding the policy levers that influence the advancement of innovation from universities into the commercial market ... more.. Dr. Ted TorphyTed is Vice President and Global Head of External Innovation & Business Models for CREATe within Johnson & Johnson’s Pharmaceuticals Group. In this role he is responsible for building and managing a portfolio of external R&D collaborations on... more..Dr. Corey GoodmanDr. Corey Goodman is a Founding Partner of venBio – a new life sciences strategic capital company working with Amgen, Baxter, and PPD. With a B.S. from Stanford University and Ph.D. from U.C. Berkeley, he spent 25 years as a biology professor at... more..Mr Bernard MunosBernard Munos is the founder of the InnoThink Center for Research in Biomedical Innovation, which was created to translate innovation research into better evidence-based business models for the pharmaceutical industry and its stakeholders. Before... more.. Dr. Thomas HughesThomas Hughes, PhD has more than 24 years of experience in the biomedical and pharmaceutical research and development. Dr. Hughes is President and CEO of Zafgen, Inc – a biotech company focused on treatment of severe obesity and its related... more.. Mr. Steve BurrillG. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for over 40 years. An early pioneer, Mr. Burrill is one of the original architects of the industry and one of its most avid and sustained developers. He... more..
| ||
| 5.20pm | Close of conference |
Register for World Pharma Innovation Congress USA ›
